Eversept Partners’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.1M | Buy |
|
|||||
|
2025
Q1 | $12.6M | Sell |
|
|||||
|
2024
Q4 | $18.2M | Buy |
|
|||||
|
2024
Q3 | $19.2M | Sell |
|
|||||
|
2024
Q2 | $23.4M | Sell |
|
|||||
|
2024
Q1 | $29.8M | Sell |
|
|||||
|
2023
Q4 | $29.9M | Buy |
|
|||||
|
2023
Q3 | $16.2M | Sell |
|
|||||
|
2023
Q2 | $26.7M | Buy |
|
|||||
|
2023
Q1 | $24.8M | Buy |
|
|||||
|
2022
Q4 | $24.9M | Sell |
|
|||||
|
2022
Q3 | $17.6M | Buy |
|
|||||
|
2022
Q2 | $14.9M | Sell |
|
|||||
|
2022
Q1 | $21.7M | Buy |
|
|||||
|
2021
Q4 | $22.9M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.23M | Sell |
|
|||||
|
2020
Q2 | $9.27M | Buy |
|